Background
The Notch family of receptors controls a broad range of cell fate decisions in vertebrates and invertebrates; it is thus a key regulator of development. The receptors themselves have been well conserved and consist of an extracellular ligand-binding domain with multiple tandemly arranged EGF-like motifs and also characteristic LN repeats. In a process still not fully understood, ligand binding induces the proteolytic cleavage of the Notch intracellular domain, which then translocates to the nucleus, where it participates in a transcriptional activation complex [1, 2] . Drosophila Notch is activated by two well established ligands, Delta and Serrate, although there are other extracellular proteins that have been proposed to also bind to, and modulate, the receptor [3, 4] . Delta and Serrate are similar in structure, each having a transmembrane domain and, like the receptor, a tandem array of EGF domains [5] [6] [7] .
In both the eye and wing imaginal discs, an interplay of Delta and Serrate is required for the generation of organising centres that coordinate the growth and patterning of the discs [8] [9] [10] . This has been best studied in the wing, where Notch signalling at the boundary between the dorsal and ventral compartments triggers the expression of margin-specific genes, including the secreted protein Wingless, which acts over a long distance to regulate wing development. This crucial activation of Notch at the wing margin is controlled by Serrate, which is expressed only on the dorsal side of the margin, and Delta, whose expression is limited to the ventral side of the margin. Genetic evidence shows that Serrate efficiently activates Notch only in the ventral cells (that is, where it is not itself expressed) and, similarly, Delta activates Notch only in the dorsal cells. These restrictions ensure that Notch activity is limited to only the cells at the boundary between the dorsal and ventral compartments. The molecular mechanism that spatially restricts the function of the two ligands, which appear to be functionally equivalent, is not understood but is dependent on the product of the fringe gene [11] [12] [13] [14] [15] [16] .
Like Notch and its ligands, Fringe has been well conserved through evolution, as has its role in modulating Notch signalling at important developmental boundaries [17] [18] [19] [20] [21] [22] [23] . Fringe has frequently been proposed to be a secreted signalling protein by virtue of a putative signal peptide near its amino terminus (for example [4, 14, [24] [25] [26] ); it is also cysteine-rich, leading to the proposal that it might form a type of 'cysteine-knot' structure, typical of several growth factors [14] . An alternative view was suggested when it was discovered that Fringe proteins have some sequence similarities to a family of bacterial glycosyltransferases: it was proposed that Fringe may be a secreted glycosyltransferase that acts by regulating the glycosylation of proteins involved in Notch signalling [27] .
These two hypotheses, Fringe as a secreted signal or Fringe as an extracellular glycosyltransferase, both continue to be advocated and are sufficiently distinct to cause confusion in the interpretation of data relating to Fringe function. We have tried to clarify this issue and here report that Drosophila Fringe is a Golgi-localised protein that has the hallmarks of a glycosyltransferase: it binds UDP specifically and mutation of a single amino acid in the putative enzyme active site is sufficient to abolish its function. Moreover, our evidence indicates that Fringe does not function extracellularly.
Results

Drosophila Fringe is localised in the Golgi apparatus
We made a Myc-tagged version of Fringe and expressed it in transgenic Drosophila using the UAS-Gal4 system [28] ( Figure 1 ). Ectopic expression of the Myc-tagged Fringe confirmed that the protein was functional (see below). When uniformly expressed in embryos under the control of armadillo-Gal4, the Myc-tagged Fringe was found by immunofluorescence to be in punctate structures in all cells (Figure 2a,b) . Drosophila cells are relatively small, and the Golgi apparatus is not organised into the characteristic perinuclear cluster of ribbons typical of mammalian cells [29, 30] . To determine whether the punctate structures were Golgi, we double-labelled embryos with a Golgi-specific monoclonal antibody [29] . Fringe colocalised with the Golgi marker precisely, demonstrating that Fringe principally resides in the Golgi apparatus. We then looked at the location of Fringe expressed in the large polyploid cells of the larval salivary gland, under the control of the AB1-Gal4 line (Figure 2c ). The cells around the duct of the gland stained well with the Golgi marker and we found them to have very large amounts of Golgi, appropriate for their secretory function. In these cells, too, Fringe was localised specifically to the Golgi apparatus.
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Figure 1
Structure of Fringe and SP-Fringe. (a) Organisation of Fringe, with the amino-terminal hydrophobic region and the conserved DxD motif indicated. (b) Amino-terminal sequences of Fringe and SP-Fringe, a derivative in which the hydrophobic amino terminus of Fringe is replaced with the signal peptide of the secreted protein Argos (lower case). The hydrophobic stretch at the Fringe amino terminus is boxed, and the putative signal peptide cleavage site proposed to exist in Fringe [14] and Argos is marked with open and filled arrows, respectively. (c) Anti-Myc immunoblot of proteins prepared from transgenic Drosophila embryos expressing the indicated Myc-tagged versions of Fringe. Drosophila Fringe is predicted to contain several sites for addition of O-linked glycans (between residues 72 and 145) and the protein migrates as a heterogeneous band with an apparent size greater than predicted, suggesting that these sites are being modified. 
Figure 2
Wild-type Myc-tagged Fringe is located in the Golgi apparatus. A stretch of hydrophobic amino acids near the amino terminus is a conserved feature of Drosophila and vertebrate Fringe proteins and has led to the proposal that these proteins are secreted [4, 14, [24] [25] [26] . In order to test this, we replaced this putative signal peptide with that from a well established secreted protein, Argos, an antagonistic ligand of the EGF receptor [31] (Figure 1b) . Western blotting of protein extracts from embryos expressing this chimera (SP-Fringe) showed that it is smaller than the full-length protein (Figure 1c) . If the hydrophobic stretch from fulllength Fringe were being removed by signal peptidase, it would be predicted to leave a protein that is a few residues smaller than that produced when the Argos signal peptide is removed from SP-Fringe (Figure 1b) . The larger size of wild-type Fringe implies that it is not in fact cleaved at the putative signal peptide, but instead the protein remains attached to its amino-terminal hydrophobic stretch.
We then examined the localisation of Myc-tagged SP-Fringe in transgenic Drosophila. In contrast to the wild-type protein, SP-Fringe is not found in the Golgi apparatus, but instead has a marked extracellular appearance. In embryos, SP-Fringe outlines cells and appears to fill the extracellular space (Figure 3a ,b). Even more dramatically, SP-Fringe is secreted into the lumen of the salivary gland duct (Figure 3c ). In the embryo, we do not see any clear intracellular staining of SP-Fringe, although in the salivary gland there is weak staining, which at least partially co-localises with the Golgi apparatus, and which we suspect is the secreted protein in transit through the secretory pathway.
Secreted Fringe has reduced activity
It is, in principle, possible that a small amount of wildtype Fringe is released from the Golgi apparatus and secreted, and this could be the functional form of the protein. We tested this by comparing the in vivo activity of wild-type Fringe with that of SP-Fringe. The assay used was the ectopic expression of Fringe in the eye and the wing. At the dorsal-ventral boundary of both the eye and wing imaginal discs, a juxtaposition of Fringe-expressing and non-expressing cells is required to establish a narrow domain of Notch signalling; when this boundary of Fringe is disrupted by its ectopic expression, the Notch signalling is lost and the organising centre abolished. This leads to developmental defects, including reduction in the size of the eye and wing [8, 11] . We expressed each UAS-fringe construct under the control of several Gal4 drivers: eyeless-Gal4, patched-Gal4, scalloped-Gal4 and klumpfuss-Gal4. Although, when expressed at very high levels, SP-Fringe and the wild-type protein caused severe and indistinguishable abnormalities, at lower expression levels, SP-Fringe caused much less severe defects than the wild-type protein. For example, under the control of patched-Gal4, wild-type Fringe causes a reduction in size of the eye and a disruption of the regular array of ommatidia that comprise the compound eye ( Figure 4a ); in contrast, SP-Fringe expressed under the control of the same driver barely disrupts eye development ( Figure 4b ). When the genes are expressed at slightly higher levels, for example in the eye, under the control of eyeless-Gal4 at 18°C or in the wing under the control of klumpfuss-Gal4, SP-Fringe does have detectable activity (Figure 4d ,f), but it is much less than the wild-type protein (Figure 4c ,e). These results imply that forcing Fringe to be secreted substantially reduces its ability to function. We suspect that the weak residual activity of SP-Fringe is due to its transient presence in the Golgi apparatus as it moves through the secretory pathway (see below).
In summary, the results described above show that wildtype Fringe is a Golgi-localised protein and that this localisation is necessary for its efficient action: secretion of Fringe impairs its function. These observations are inconsistent with a model in which a putative secreted fraction of the protein is the active pool, and we therefore propose that Fringe functions in the Golgi apparatus.
Fringe binds specifically to UDP
The Golgi localisation of Fringe raises the question of how it acts in this organelle to affect Notch signalling. The Golgi apparatus is where the wide array of complex glycan structures are added to core carbohydrates, which are attached to secreted proteins in the endoplasmic reticulum and early Golgi. As Fringe has distant homology to known glycosyltransferases, an appealing possibility is that it is itself a Golgi glycosyltransferase. One of the characteristics of Golgi glycosyltransferases is that, like many other glycosyltransferases, they use nucleoside sugars as donors, and in the majority of cases this nucleoside is UDP. The presence of a UDP-binding site in Fringe was thus investigated by UV crosslinking. Myc-tagged SP-Fringe was expressed in COS cells and the medium collected and concentrated. Figure 5a shows that a Myc-tagged 70 kDa protein appears in the medium of cells expressing the SP-Fringe plasmid. When a radiolabelled photoactivatable UDP analogue was incubated with the control medium, several minor bands were labelled in a UV-dependent manner. In the SP-Fringe-expressing cells, a strongly labelled 70 kDa band was also present, indicating that the SP-Fringe product was labelled. This labelling was competed by unlabelled UDP, but not by GDP, CDP or ADP (Figure 5b ). Wild-type Fringe also showed crosslinking to UDP, with a similar sensitivity to competition (Figure 5c ).
Thus, it appears that Fringe specifically binds to UDP, a characteristic of many glycosyltransferases. Moreover, the unaltered ability of SP-Fringe to bind UDP, along with its efficient secretion, indicates that its reduced biological activity is not simply caused by misfolding, but rather reflects its transient presence in the Golgi apparatus. When known glycosyltransferases are converted to secreted forms, they have been observed to continue to modify substrates but at a reduced level [32, 33] .
The DxD active-site motif of glycosyltransferases is required for Fringe function
In the region most conserved within the Fringe family, which is also where there is some similarity to more distantly related glycosyltransferases, there is a DxD motif, a hallmark of the catalytic site of many nucleoside diphosphate-binding glycosyltransferases [34, 35] . We tested whether this predicted active site was required for Fringe function by mutating the first aspartate (236) to an alanine (DDD to ADD; Figure 6a) , and assaying the function and localisation of the Myc-tagged ADD-Fringe. When expressed in embryos or salivary gland duct cells, ADD-Fringe was localised in the Golgi (Figure 6b,c) , indistinguishably from the wild-type Fringe, suggesting that the mutant protein is stably expressed and normally folded. Consistent with this, ADD-Fringe binds UDP indistinguishably from the wild type (Figure 5d ). The DxD motif is believed to serve to coordinate a manganese ion required for catalysis, whereas residues elsewhere are responsible for binding the nucleotide and sugar in an enzyme-specific manner [35] . However, when the biological activity of ADD-Fringe was assayed by ectopic expression with the same range of Gal4 expression drivers as described above, the ADD-Fringe mutant was completely inert under all conditions, even when expressed at high levels, for example under the control of eyeless-Gal4 in the eye, or klumpfuss-Gal4 in the wing (Figure 6d-g ).
Even the strongest wing driver, patched-Gal4, failed to produce a phenotype when used to express ADD-Fringe (data not shown). Therefore, a single amino acid alteration in the putative glycosyltransferase active site abolishes all Fringe activity.
Discussion
The protein Fringe has been found in many systems to have a critical role in modulating the response of the Notch receptor to different ligands; in Drosophila its function is to allow the receptor to discriminate between very similar ligands, Delta and Serrate. However, the mechanism by which it exerts this effect is unknown. A hydrophobic stretch at the amino terminus of Fringe resembling a cleaved signal peptide led to the hypothesis that Fringe is itself a secreted signalling molecule (for example [4, 14, [24] [25] [26] ). An alternative possibility, that the protein is secreted but has an enzymatic role, was suggested by the distant structural relationship between Fringe and bacterial glycosyltransferases [27] . In this paper we report that 
Grasshop. 20 Fringe is localised and functions in the Golgi apparatus and has the characteristics of many families of glycosyltransferases that use nucleoside diphosphate sugars. The simplest interpretation of our results is that Fringe is a Golgi-localised glycosyltransferase. Although distinct from both previous models, we discuss below how this interpretation can be reconciled with previous studies.
The suggestion that Fringe is secreted came from the amino-terminal hydrophobic stretch, which was predicted to be a leader peptide [14, 25] . Golgi glycosyltransferases are, almost without exception, Type II membrane proteins with a single transmembrane domain within the first 5-50 residues of the amino terminus [36] . Because the transmembrane domains of Golgi proteins are usually shorter than those of plasma membrane proteins [37] , their amino-terminal regions can appear similar to signal peptides. Indeed, the best current signal-peptide prediction programmes incorrectly predict known mammalian glycosyltransferases to have cleaved amino termini (S.M., unpublished observations). The fact that, when attached to a confirmed signal peptide, Fringe is secreted and has a smaller apparent size, strongly suggests that the amino-terminal hydrophobic stretch is not normally cleaved, but rather is a transmembrane domain typical of Golgi glycosyltransferases. A previous examination of Fringe expressed in transgenic flies concluded that the protein was being secreted on the basis that it could be detected outside of the expression domain of the GAL4 expression driver being used [11] . This 'extracellular' Fringe appeared in a punctate pattern strikingly similar to the Golgi localisation described here, raising the possibility that it was in fact weak ectopic expression of the protein, caused by leakiness of the Gal4 driver. Furthermore, even if a small amount of Fringe is secreted, we have shown that forcing its secretion dramatically reduces its activity, indicating that it is the intracellular form, rather than the secreted form that regulates Notch signalling. An intracellular site of action for Fringe is also easier to reconcile with the protein's observed cell autonomy in regulating Notch [11] .
Fringe has been previously noted to share some sequence similarity with glycosyltransferases [27] , and in this paper we provide evidence that this homology reflects an homologous function rather than simply a related structure. Fringe specifically binds the nucleoside diphosphate UDP and is inactivated by mutation of its conserved DxD sequence, a conserved active-site motif shared by many families of glycosyltransferases that use nucleoside diphosphate sugars [34, 35, 38] . Glycosyltransferase activity is again more consistent with a Golgi site of action, as nucleoside diphosphate sugars are unlikely to reach a significant concentration in the extracellular space.
Overall, our data are hard to reconcile with Fringe being a secreted signalling protein, but instead strongly favour it being a Golgi-localised glycosyltransferase. How then could such an activity explain the regulation of Notch signalling? The simplest explanation is that Fringe glycosylates Notch itself. Fringe is expressed only in a subset of cells, indicating that it is not involved in widespread glycan modifications. However, Notch contains over thirty EGF repeats, and in mammalian cells two sets of unusual O-linked sugar structures specific to EGF domains, initiated by either glucose or fucose, have been identified [39] . Consensus sequences for these modifications are conserved between the EGF repeats of Drosophila and mammalian Notch proteins, and the modifications have been found on human Notch1 [40] . Fringe has recently been reported to bind Notch [24] and, interestingly, the fucosyltransferase responsible for initiating O-linked fucosylation binds tightly to an EGF-repeatcontaining substrate [41] . Highly protein-specific modification may well require high-affinity interactions with substrates. Of course, formal proof of the glycosyltransferase function of Fringe will require in vitro enzyme studies but, nevertheless, we consider that the evidence presented here makes this model compelling.
Specific modification by Fringe of one or more of the Olinked structures on the Notch EGF repeats could alter the binding affinity of the ligands Delta and Serrate. Specifically, genetic evidence implies that Serrate binding and/or activation of Notch would be inhibited by Fringemediated glycosylation, whereas Delta binding and/or activation would be enhanced. This prediction should be testable in future in vitro studies. Delta and Serrate both bind EGF repeats 11 and 12 of Notch [42] , the latter of which contains a well conserved site for O-linked glucosylation. However, the situation may be more complex, as Abruptex mutations in Notch that map to EGF repeats 24, 25, 27 or 29 have interestingly been found to be insensitive to modulation by Fringe [43] . It may be that recognition or modification of many of the Notch repeats is critical for affecting ligand binding.
A role for Fringe in Notch glycosylation would imply that site-specific glycosylation is a means by which cells can modulate the ligand-responsiveness of specific receptors. This conclusion clearly has widespread potential significance for understanding the interactions between extracellular ligands and their receptors. Fringe is well conserved between Drosophila and mammals, and mammalian Fringes seem likely to have similar roles to that of the Drosophila protein. Indeed, mouse Manic Fringe, one of the three closely related mammalian Fringes, is also located in the Golgi (S.M., unpublished observations). It remains to be established whether the principle of modulating receptor specificity by glycosylation extends to further signalling systems, but our results suggest that it is a good explanation for the mechanism by which Fringe regulates Notch signalling.
Materials and methods
Cloning and constructs
Drosophila Fringe cDNA was amplified by PCR and cloned with a triple Myc tag so that the carboxyl terminus of the protein was extended by the residues GTGAGAGA(EQKLISEEDLG) 3 AG. Mutation of Asp236 to alanine, and insertion of a site for attachment of the Argos signal peptide were also performed by PCR, with all amplified products checked by sequencing. For expression in flies, tagged proteins were cloned into the P-element vector pUAST [28] . For expression in COS cells, the Myc-tagged versions of Fringe, SP-Fringe and SP-ADDFringe were cloned into SMH3, a vector with an adenovirus major late promoter and a SV40 replication origin, to make plasmids SADFgM1, SADFgM3 and SADFgM4, respectively.
Fly stocks
The following Gal4 expression drivers were used to misexpress the fringe constructs: AB1-Gal4 (an uncharacterised salivary gland driver), armadillo-Gal4, eyeless-Gal4, klumpfuss-Gal4, patched-Gal4 and scalloped-Gal4. All are described in Flybase (http://fly.ebi.ac.uk:7081/).
Histology
Embryos were immunostained by standard protocols [44] ; salivary glands were fixed in 4% paraformaldehyde and stained by standard techniques in the presence of 0.1% Triton X-100. The following antibodies were used: rabbit anti-Myc (Santa Cruz Biotechnology) at 1:500, and anti-120 kDa [29] , which is a marker for Drosophila Golgi apparatus. Alexa-594 (red) and Alexa-488 (green)-conjugated secondary antibodies from Molecular Probes were used at 1:200. Scanning electron microscopy was performed by standard techniques [45] .
UV crosslinking
To prepare soluble Fringe, COS cells in 10 cm plates were transfected with either SADFgM3, SADFgM4, or a control plasmid (Fugene, Roche). At 24 h after transfection, cells were rinsed once with serumfree medium (Optimem, Life Technologies), and 3.5 ml serum-free medium applied per plate. After 24 h, medium was collected, cleared by centrifugation (3000g, 10 min), concentrated 20-fold (Centriprep YM-10, Amicon) and dialysed against GT2 buffer (50 mM 2-[Nmorpholino]ethanesulphonic acid pH 6.8, 50 mM NaCl, 10 mM MnCl 2 , 20% glycerol), all steps at 4°C. After clarification (10,000g, 10 min), concentrated medium was stored at -70°C until further use. To prepare wild-type Fringe, COS cells were transfected as above with SADFgM1 and 44 h post-transfection scraped into PBS, pelleted (1000g, 5 min) and lysed in 250 µl lysis buffer per plate (1% Triton X-100, 150 mM NaCl, 25 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM phenylmethylsulphonyl fluoride). After centrifugation (10,000g, 10 min) agarose beads coupled to the anti-Myc monoclonal 9E10 were added to the supernatant, rolled for 3 h, washed four times in lysis buffer and resuspended in GT2 buffer containing 1% Triton X-100 (25 µl per plate), all steps at 4°C. Myc-tagged SP-Fringe was immunoprecipitated from concentrated medium, prepared as above and diluted sixfold into lysis buffer.
Phosphorylation of 4-thioUMP to prepare [β-32 P]4-thioUDP was based on previous methods [46, 47] . Briefly, a 10 µl reaction containing 0.5 mM 4-thioUMP (Sigma), 40 mM Tris-HCl pH 7.4, 22 mM MgCl 2 , 50 mM DTT and 80 µCi [γ-32 P]ATP (3000 Ci/mmol, Amersham) and 7.5 milliunits of nucleoside monophosphate kinase (Roche) was incubated at 20°C for 60 min and then stored at -70°C until further use.
For UV-crosslinking, 25 µl reactions in GT2 buffer, containing 20 µl of concentrated cell medium or 10 µl immunoprecipitated beads, and 0.1 µl of above kinase reaction, 1 mg/ml soybean trypsin inhibitor and, if present, unlabelled competitor nucleoside diphosphate, were placed in wells of a 96-well plate on ice. UV exposure was with a Blak-Ray B100AP lamp (365 nM filter, UV Products), and then 25 µl 2× SDS buffer was added, samples heated to 65°C and 20 µl separated by SDS-PAGE. Gels were fixed, stained with Coomassie blue, dried onto paper and exposed to film or phosphorimager screen for 8-24 h.
Because Current Biology operates a 'Continuous Publication System' for Research Papers, this paper has been published on the internet before being printed. The paper can be accessed from http://biomednet.com/cbiology/cub -for further information, see the explanation on the contents page.
